Filament Health Corp (FH) - Cash Flow Conversion Efficiency

Latest as of March 2025: -0.228x

Based on the latest financial reports, Filament Health Corp (FH) has a cash flow conversion efficiency ratio of -0.228x as of March 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CA$-221.75K ≈ $-160.41K USD) by net assets (CA$974.38K ≈ $704.85K USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See Filament Health Corp (FH) net asset quality to measure how much of total assets are equity-financed.

Filament Health Corp - Cash Flow Conversion Efficiency Trend (2020–2024)

This chart illustrates how Filament Health Corp's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check Filament Health Corp cash flow reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.

Filament Health Corp Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Filament Health Corp ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Redcentric LSE:RCN	0.133x
DMC Mining Ltd AU:DMM	0.294x
Baiya International Group Inc. Ordinary Shares NASDAQ:BIYA	N/A
Starbreeze AB (publ) ST:STAR-A	-0.015x
Kore Potash Plc LSE:KP2	0.000x
KINGS ENTERTAINMENT GROUP F:L12	N/A
Direct Digital Holdings Inc NASDAQ:DRCT	0.108x
BT Wealth Industries Public Company Limited BK:BTW	-0.152x

Annual Cash Flow Conversion Efficiency for Filament Health Corp (2020–2024)

The table below shows the annual cash flow conversion efficiency of Filament Health Corp from 2020 to 2024. For the full company profile with market capitalisation and key ratios, see Filament Health Corp stock valuation.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-12-31	CA$1.75 Million ≈ $1.26 Million	CA$-2.29 Million ≈ $-1.66 Million	-1.310x	+22.06%
2023-12-31	CA$2.49 Million ≈ $1.80 Million	CA$-4.19 Million ≈ $-3.03 Million	-1.681x	-38.80%
2022-12-31	CA$3.19 Million ≈ $2.31 Million	CA$-3.87 Million ≈ $-2.80 Million	-1.211x	-270.68%
2021-12-31	CA$16.55 Million ≈ $11.97 Million	CA$-5.41 Million ≈ $-3.91 Million	-0.327x	-247.81%
2020-12-31	CA$813.64K ≈ $588.58K	CA$-76.42K ≈ $-55.28K	-0.094x	--

About Filament Health Corp

NEO:FH Canada

Market Cap

$1.89 Million

CA$2.62 Million CAD

Market Cap Rank

#30042 Global

#1493 in Canada

Share Price

CA$0.01

Change (1 day)

+0.00%

52-Week Range

CA$0.01 - CA$0.01

All Time High

CA$0.40